Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes
Authors:
- 22 February 2016
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 31 (6) , 623-629
Abstract
BACKGROUND Many smokers admitted for chronic obstructive pulmonary disease (COPD) are not given smoking cessation medications at discharge. The reasons behind this are unclear, and may reflect an interplay of patient characteristics, health disparities, and the receipt of inpatient tobacco control processes. OBJECTIVES We aimed to assess potential disparities in treatment for tobacco use following discharge for COPD, examined in the context of inpatient tobacco control processes. PARTICIPANTS Smokers aged ≥ 40 years, admitted for treatment of a COPD exacerbation within the VA Veterans Integrated Service Network 20, identified using ICD-9 discharge codes and admission diagnoses from 2005–2012. MAIN MEASURES The outcome was any tobacco cessation medication dispensed within 48 hours of discharge. We assessed potential predictors administratively up to 1 year prior to admission. We created the final logistic regression model using manual model building, clustered by site. Variables with p < 0.2 in biviariate models were considered for inclusion in the final model. RESULTS We identified 1511 subjects. 16.9 % were dispensed a medication at discharge. In the adjusted model, several predictors were associated with decreased odds of receiving medications: older age (OR per year older 0.96, 95 % CI 0.95–0.98), black race (OR 0.34, 95 % CI 0.12–0.97), higher comorbidity score (OR 0.89, 95 % CI 0.82–0.96), history of psychosis (OR 0.40, 95 % CI 0.31–0.52), hypertension (OR 0.75, 95 % CI 0.62–0.90), and treatment with steroids in the past year (OR 0.80, 95 % CI 0.70–0.90). Inpatient tobacco control processes were associated with increased odds of receiving medications: documented brief counseling at discharge (OR 3.08, 95 % CI 2.02–4.68) and receipt of smoking cessation medications while inpatient (OR 5.95, 95 % CI 3.19–11.10). CONCLUSIONS Few patients were treated with tobacco cessation medications at discharge. We found evidence for disparities in treatment, but also potentially beneficial effects of inpatient tobacco control measures. Further focus should be on using novel processes of care to improve provision of medications and decrease the observed disparities.Keywords
This publication has 54 references indexed in Scilit:
- Successful Smoking Cessation in COPD: Association with Comorbidities and MortalityPulmonary Medicine, 2012
- Nicotine Replacement Therapy Use at Home After Use During a HospitalizationNicotine & Tobacco Research, 2011
- Validating Smoking Data From the Veteran's Affairs Health Factors Dataset, an Electronic Data SourceNicotine & Tobacco Research, 2011
- A Nationwide Analysis of US Racial/Ethnic Disparities in Smoking Behaviors, Smoking Cessation, and Cessation-Related FactorsAmerican Journal of Public Health, 2011
- Evaluation of a hospital‐based tobacco treatment service: Outcomes and lessons learnedJournal of Hospital Medicine, 2010
- Socioeconomic status, race and COPD health outcomesJournal of Epidemiology and Community Health, 2009
- Smoking and mental illness: results from population surveys in Australia and the United StatesBMC Public Health, 2009
- Smoking care provision in hospitals: A review of prevalenceNicotine & Tobacco Research, 2008
- Racial/Ethnic Disparities in Report of Physician-Provided Smoking Cessation Advice: Analysis of the 2000 National Health Interview SurveyAmerican Journal of Public Health, 2006
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992